MEDXF
Medexus Pharmaceuticals Inc
CEO
Kenneth D'Entremont
Industry
Medicinal and Botanical Manufacturing
Loading...
Open
1.49
Mkt cap
38M
Volume
1.6K
High
1.56
P/E Ratio
17.00
52-wk high
2.35
Low
1.48
Div yield
N/A
52-wk low
1.06
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.